In carriers of the pathogenic variant in the PALB2 gene, a lifetime risk for the development of breast cancer is 40%–60%, for ovarian cancer 3%–5%, and for pancreatic cancer 2%–3%. The gene discussed is PALB2; the disease is ovarian cancer.